Amylin Advises All Shareholders to Vote Their Blue Proxy ...(dered at the 2009 Annual Meeting of Stoc...),Health

Date:5/26/2009

dered at the 2009 Annual Meeting of Stockholders. Amylin has filed the definitive proxy statement with the Securities and Exchange Commission ("SEC") on April 20, 2009. INVESTORS AND SECURITYHOLDERS ARE URGED TO READ THE PROXY STATEMENT, THE BLUE PROXY CARD AND ANY OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Investors and securityholders may obtain the proxy statement and other relevant documents free of charge at the SEC's Web site, www.sec.gov or from Amylin Investor Relations at 9360 Towne Centre Drive, San Diego, California 92121.

Participants in Solicitation

Amylin and its directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the matters to be considered at the 2009 Annual Meeting of Stockholders. Information regarding the interests of Amylin's directors and executive officers in the proxy contest is included in Amylin's definitive proxy statement.

    CONTACTS:

    Alice Izzo
    Executive Director, Corporate Affairs
    Amylin Pharmaceuticals, Inc.
    (858) 642-7272
    alice.izzo@amylin.com

    or

    Joele Frank / Jim Golden
    Joele Frank, Wilkinson Brimmer Katcher
    (212) 355-4449

'/>"/>

SOURCE Amylin Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4
Related medicine news :

1. Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
2. Amylin Issues Statement Regarding Open Letter From Icahn
3. Icahn Issues Open Letter to Amylin Shareholders
4. Amylin Sends Letter to Shareholders
5. Amylin Pharmaceuticals Reports First Quarter Financial Results
6. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
7. Amylin Pharmaceuticals to Webcast First Quarter Results
8. Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders
9. Amylin Pharmaceuticals Comments on Shareholder 13-D Filing
10. Amylin Pharmaceuticals Reports 2008 Financial Results
11. Amylin Pharmaceuticals to Webcast Year-End Results